Subscribe and Stay Informed
Receive industry-leading content from our experts

Start exploring
Does mRNA Require IBC Review? How the NIH Guidelines Apply to Clinical Trials
Let me start with a question I get more and more frequently from research sites…
Sponsor’s Guide to IRB Approval (Part III): Building an IRB-Ready Informed Consent
Sponsor’s Guide to IRB Approval (Part III): Building an IRB-Ready Informed Consent For sponsors, informed…
A More Connected Approach to Clinical Trials: Reducing Friction from Study Design Through Conduct
Clinical trials are complex. That’s expected, given accelerated advancements in science and technology. But when…
Sponsor’s Guide to IRB Approval (Part II): How to Draft a Clinical Trial Protocol That Stands Up to IRB ScrutinyÂ
A strong clinical trial protocol does more than describe how a study will run. It…
Gene Therapy Is Seen as the Next Big Biologic in Ophthalmology
Over the last 15 to 20 years, monoclonal antibody-based treatments, such as those targeting vascular…
Protocol Amendments Don’t Have to Create Chaos
Key takeaways from the Collaboration Lab Workshop at the Advarra Innovation Summit at Research Triangle…